Capmark Finl Group I (CPMK) 6.3500 $CPMK Capmark

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Capmark Finl Group I (CPMK) 6.3500 $CPMK

Capmark Financial Group Inc. Announces Corporate Name Change to Bluestem Group Inc. and Election of Directors
BusinessWire - Thu Jun 18, 3:00PM CDT
Capmark Financial Group Inc. (OTCMKTS: CPMK) today announced that it has changed its corporate name to Bluestem Group Inc. "Bluestem Group better reflects the company's operating businesses, including our wholly-owned subsidiary, Bluestem Brands," said Chidam Chidambaram, Bluestem Group's Chief Marketing Officer. Bluestem operates through its Fingerhut and Gettington retail brands, each of which offers a large selection of merchandise with a variety of payment options to provide customers with the flexibility of paying over time. Bluestem also operates through PayCheck Direct, an employee purchase program.

Capmark Financial Group Inc. Announces Unaudited Consolidated First Quarter 2015 Earnings Results
BusinessWire - Tue Jun 16, 8:00AM CDT
Capmark Financial Group Inc. (OTCMKTS: CPMK) today reported unaudited consolidated financial results that include its wholly-owned subsidiary, Bluestem Brands, Inc. and its subsidiaries, for the 13-week period ended May 1, 2015 (we refer to the 13-week periods ended May 1, 2015 and May 2, 2014 in this release as respectively the "first quarter" of fiscal 2015 and fiscal 2014). Bluestem, which merged with Capmark on November 7, 2014, is a multi-brand, online retailer of name-brand and private label general merchandise serving low- to middle-income consumers nationwide.

Capmark Financial Group Inc. to Release Unaudited Consolidated First Quarter 2015 Earnings Results
BusinessWire - Mon Jun 01, 3:01PM CDT
Capmark Financial Group Inc. (OTCMKTS:CPMK) will release unaudited consolidated financial results that include its wholly-owned subsidiary, Bluestem Brands, Inc. and its subsidiaries, for the 13-week period ended May 1, 2015 on Tuesday, June 16, 2015. Steve Nave, CEO, and Mark Wagener, CFO, will host a conference call at 8:00 AM ET on June 17, 2015 to discuss the results. The conference call can be accessed at (888) 329-8862 or (719) 325-2354 (International). The call will also be broadcast simultaneously at http://www.capmark.com/investor-relations. Following completion of the call, a recorded replay of the webcast will be available on Capmark's website. To listen to the telephone replay, call toll-free (877) 870-5176 or (858) 384-5517 (International), replay pin # 5383157. The telephone replay will be available at 8:00 PM ET June 17, 2015. Additional investor information can be accessed at http://www.capmark.com/investor-relations.

Capmark Financial Group Inc. Announces Acquisition of Orchard Brands
BusinessWire - Wed May 27, 4:40PM CDT
Capmark Financial Group Inc. (OTCMKTS: CPMK) today announced it has entered into a definitive agreement to acquire Orchard Brands Corporation, a leading national, multi-brand family of 13 catalog and eCommerce brands serving the boomer and senior demographics, for $410 million in cash, subject to various pre- and post-closing adjustments. The transaction will broaden and diversify the customer base and retail capabilities of Capmark's wholly-owned subsidiary, Bluestem Brands, Inc.

Capmark Financial Group Inc. Announces Unaudited Consolidated Fourth Quarter and Full Year 2014 Earnings Results
BusinessWire - Tue Apr 28, 3:01PM CDT
Capmark Financial Group Inc. (OTCMKTS: CPMK) today reported unaudited consolidated financial results that include its wholly-owned subsidiary, Bluestem Brands, Inc. and its subsidiaries, for Capmark's and Bluestem's 13- and 52-week periods ended January 30, 2015 (we refer to the 13-week periods ended January 30, 2015 and January 31, 2014 in this release as respectively the "fourth quarter" of fiscal 2014 and fiscal 2013). Bluestem, which merged with Capmark on November 7, 2014, is a multi-brand, online retailer of name-brand and private label general merchandise serving low- to middle-income consumers nationwide.

Capmark Financial Group Inc. to Announce Preliminary Unaudited Consolidated Fourth Quarter and Full Year 2014 Earnings Results on April 28, 2015
BusinessWire - Thu Apr 23, 3:30PM CDT
Capmark Financial Group Inc. (OTCMKTS:CPMK) will announce preliminary unaudited consolidated financial results that include its wholly-owned subsidiary, Bluestem Brands, Inc. and its subsidiaries, for Capmark's and Bluestem's 13- and 52-week periods ended January 30, 2015 on Tuesday, April 28, 2015 after the market close.

Capmark Financial Group Inc. Announces Stand-Alone Third Quarter 2014 Earnings Results for its Wholly-Owned Subsidiary, Bluestem Brands, Inc.
BusinessWire - Tue Dec 23, 3:01PM CST
Capmark Financial Group Inc. ("Capmark" today reported stand-alone historical consolidated financial results of its wholly-owned subsidiary, Bluestem Brands, Inc. and its subsidiaries ("Bluestem" , for Bluestem's 13- and 39-week periods ended October 31, 2014 (we refer to the 13-week periods ended October 31, 2014 and November 1, 2013 in this release as the "third quarter" . Bluestem, which merged with Capmark on November 7, 2014, is a multi-brand, online retailer of name-brand and private label general merchandise serving low- to middle-income consumers nationwide.

Capmark Financial Group Inc. to Announce Stand-Alone Third Quarter 2014 Earnings Results for its Wholly-Owned Subsidiary, Bluestem Brands, Inc. on December 23, 2014
BusinessWire - Mon Dec 22, 7:50AM CST
Bluestem Brands, Inc. ("Bluestem" , a wholly owned subsidiary of Capmark Financial Group Inc. ("Capmark" , is a multi-brand, online retailer of name-brand and private label general merchandise serving low-to-middle income consumers nationwide. Capmark will announce stand-alone historical consolidated financial results for Bluestem's 13- and 39-week periods ended October 31, 2014 on Tuesday, December 23, 2014 after the market close.

Capmark Financial Group Inc. Announces Closing of Bluestem Acquisition
BusinessWire - Fri Nov 07, 3:40PM CST
Capmark Financial Group Inc. (the "Company" today announced that it has closed its previously announced acquisition of Bluestem Brands, Inc. ("Bluestem" , a multi-brand, online retailer of name-brand and private label general merchandise serving low-to-middle income consumers nationwide, operating through its Fingerhut, Gettington.com and PayCheck Direct brands.

Capmark Financial Group Inc. To Host an Investor Meeting on November 11, 2014
BusinessWire - Thu Nov 06, 7:31AM CST
Capmark Financial Group Inc. (the "Company" today announced that in anticipation of the closing of the previously announced Bluestem acquisition it intends to host an investor meeting on Tuesday, November 11, 2014 in New York, NY from 2:00 p.m. to 4:00 p.m. (EST). The meeting will include a presentation by the Company's management regarding the Bluestem business, followed by a question and answer session.

Capmark Financial Group Inc. Issues Quarterly Report as of and for the three and nine months ended September 30, 2014 and 2013
BusinessWire - Thu Oct 23, 4:59PM CDT
Capmark Financial Group Inc. (the "Company" today issued its Quarterly Report as of and for the three and nine months ended September 30, 2014 and 2013. The Company reported consolidated net income of $38.8 million and $42.4 million for the three and nine months ended September 30, 2014, respectively. The Company also reported consolidated total assets of $579.1 million and consolidated total liabilities of $154.9 million as of September 30, 2014. Stockholders' equity increased from $373.6 million as of December 31, 2013 to $421.1 million as of September 30, 2014.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 129

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading